Geratherm Medical AG

Total Valuation

Geratherm Medical AG carries a market capitalization of 14.29M, placing it among publicly traded companies globally. Its enterprise value stands at 25.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Geratherm Medical AG currently has 5.44M shares outstanding.

Valuation Ratios

Geratherm Medical AG trades at a trailing price-to-earnings ratio of 26.94. The price-to-sales ratio is 1.00, and the price-to-book ratio stands at 5.77.

Enterprise Valuation

On an enterprise value basis, Geratherm Medical AG trades at an EV/EBITDA multiple of 8.47 and an EV/FCF ratio of 7.40. The EV/Sales ratio of 0.94 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.47 provides insight into valuation relative to core operating earnings.

Financial Position

Geratherm Medical AG maintains a current ratio of 10.78, meaning it holds 10.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.82, indicating elevated leverage, while an interest coverage ratio of 17.01 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Geratherm Medical AG posts a return on equity of 23.30 and a return on invested capital of 6.31.

Taxes

Over the trailing twelve months, Geratherm Medical AG has paid 631,095.00 in income taxes, reflecting an effective tax rate of 36.39.

Stock Price Statistics

Geratherm Medical AG's stock has declined approximately -20.48193% over the past 52 weeks. The 50-day moving average sits at 2.76, while the 200-day moving average is 3.09.

Income Statement

Over the trailing twelve months, Geratherm Medical AG generated 27.44M in revenue and converted that into 1.02M in net income, yielding earnings per share of 0.20. EBITDA reached 3.05M, while operating income came in at 3.05M.

Balance Sheet

Geratherm Medical AG holds 10.89M in cash and equivalents against 9.29M in total debt, resulting in a net debt position of 557,286.00. Total book value stands at 4.78M, with working capital of 21.37M providing operational flexibility.

Cash Flow

Geratherm Medical AG produced 2.79M in operating cash flow over the past twelve months. After subtracting -597,000.00 in capital expenditures, free cash flow totaled 2.19M - equivalent to 0.40 per share.

Margins

Geratherm Medical AG operates with a gross margin of 65.17, reflecting its pricing power and cost economics. The operating margin of 11.12 and net profit margin of 3.73 provide insight into operational efficiency.

Dividends & Yields